menu search

GNOM / GNOM: A Genomics ETF That Will Have Its Day, Even If Not Right Now

GNOM: A Genomics ETF That Will Have Its Day, Even If Not Right Now
GNOM is a $200 million ETF that invests in a forward-looking set of innovative businesses focused on the genomics industry. This is a long-term growth area, but it will need to get more profitable to get more popular. That could take a little while. Read More
Posted: May 28 2023, 04:02
Author Name: Seeking Alpha
Views: 102019

GNOM News  

GNOM: A Genomics ETF That Will Have Its Day, Even If Not Right Now

By Seeking Alpha
May 28, 2023

GNOM: A Genomics ETF That Will Have Its Day, Even If Not Right Now

GNOM is a $200 million ETF that invests in a forward-looking set of innovative businesses focused on the genomics industry. This is a long-term growth more_horizontal

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

By InvestorPlace
March 15, 2023

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these excha more_horizontal

GNOM: Get Exposure To The Latest Genomics And Biotechnology Companies

By Seeking Alpha
January 18, 2023

GNOM: Get Exposure To The Latest Genomics And Biotechnology Companies

The Global X Genomics & Biotechnology ETF tracks the Solactive Genomics Index. It invests in genomics and biotechnology companies. The fund is highly more_horizontal

3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years

By InvestorPlace
January 18, 2023

3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years

CRISPR could revolutionize the way we treat thousands of diseases.  Many of these diseases occur when mutations affect genes, or when people have the more_horizontal

Why Now Could Be The Time To Consider Neuroscience Investments

By Seeking Alpha
August 27, 2022

Why Now Could Be The Time To Consider Neuroscience Investments

Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus more_horizontal

GNOM: Poor Historical Performance, Lack Of Focus, Uncertain Future

By Seeking Alpha
March 24, 2022

GNOM: Poor Historical Performance, Lack Of Focus, Uncertain Future

GNOM lacks efficient portfolio reshuffling and may not be able to gain from higher alpha-producing stocks in the near future. more_horizontal


Search within

Pages Search Results: